Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

Parkinson’s disease is the second most common neurodegenerative ... for new patients can take an hour,” he explains. Dementia is the umbrella term for all kinds of conditions associated ...

A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

People may also refer to DLB as Lewy body dementia (LBD), but DLB is just one type of LBD. Parkinson’s disease dementia (discussed below) is the other type. People with DLB may also: experience ...

The average Montreal Cognitive Assessment (MoCA) score at screening was 19 in both groups, indicating mild to moderate ...

Neurodegenerative diseases of aging like Parkinson's disease (PD) or Alzheimer's disease (AD) are usually not diagnosed until ...

Treatments targeting alpha-synuclein aggregation account for 26% of the 7MM' pipeline disease-modifying therapies for ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

Dementia is a debilitating neurodegenerative disease that gradually diminishes life quality, leading to memory loss, ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

Brain disorders like Parkinson's disease (PD) or Alzheimer's disease (AD ... phosphorylated during the progression of PD and the related condition Lewy Body Dementia. Analyzing a cohort of patient ...